Weight loss journal
Back Edwards, K, Li, X, Linvay, I (1 April 2023) 'Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study', The Journal of Clinical Endocrinology & Metabolism , 108/ 4, 92030
Limiting Weight Regain Holistic lifestyle support complements primary care with a dedicated care team and personalized care plans
161,167 Small molecule GLP-1RAs Currently, most GLP-1RAs are based on proteins or peptides, meaning they are large molecules typically administered via injection
The EPA has extended the reporting deadline for PFAS data under the Toxic Substances Control Act (TSCA) Section 8 (a)(7) , moving the start date from November 2024 to July 2025 due to budgetary constraints and delays in developing the necessary data collection software
2023, doi: 10.3389/fendo.2023.1192629